Bellerophon Therapeutics在盘前股价暴跌39%,因公司将被纳斯达克摘牌。查看全文
临床治疗药物公司Bellerophon(BLPH.O)盘初跳涨18%,触及熔断。 网页链接
$柏勒罗丰治疗(BLPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-22-012502 Size: 8 KB 网页链接
$柏勒罗丰治疗(BLPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-22-012504 Size: 8 KB 网页链接
$柏勒罗丰治疗(BLPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-22-012506 Size: 8 KB 网页链接
$柏勒罗丰治疗(BLPH)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001600132-22-000027 Act: 34 Size: 326 KB 网页链接
$柏勒罗丰治疗(BLPH)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-22-017610 Act: 34 Size: 4 MB 网页链接
$柏勒罗丰治疗(BLPH)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001600132-22-000024 Act: 34 Size: 192 KB 网页链接
$柏勒罗丰治疗(BLPH)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001600132-22-000021 Act: 34 Size: 325 KB 网页链接
$柏勒罗丰治疗(BLPH)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-22-013565 Act: 34 Size: 4 MB 网页链接
$柏勒罗丰治疗(BLPH)$ 8-K Current report, item 5.07 Accession Number: 0001600132-22-000019 Act: 34 Size: 174 KB 网页链接
$柏勒罗丰治疗(BLPH)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001600132-22-000017 Act: 34 Size: 291 KB 网页链接